Loading...
Biome Australia Limited
BIO.AX•ASX
Healthcare
Biotechnology
A$0.53
A$0.005(0.96%)
Biome Australia Limited (BIO.AX) Financial Performance & Income Statement Overview
Review Biome Australia Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
79.79%
↑ 79.79%
Operating Income Growth
49.001%
↑ 49.001%
Net Income Growth
45.75%
↑ 45.75%
Operating Cash Flow Growth
95.32%
↑ 95.32%
Operating Margin
-0.65%
↓ 0.65%
Gross Margin
60.41%
↑ 60.41%
Net Profit Margin
1.82%
↑ 1.82%
ROE
7.76%
↑ 7.76%
ROIC
-2.18%
↓ 2.18%
Biome Australia Limited (BIO.AX) Income Statement & Financial Overview
Review Biome Australia Limited's (BIO.AX) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $8.86M | $6.99M | $6.02M | $3.85M |
| Cost of Revenue | $3.46M | $2.82M | $2.52M | $1.69M |
| Gross Profit | $5.41M | $4.17M | $3.50M | $2.16M |
| Gross Profit Ratio | $0.61 | $0.60 | $0.58 | $0.56 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $5.18M | $4.50M | $5.08M | $3.87M |
| Operating Expenses | $5.18M | $4.50M | $5.08M | $3.87M |
| Total Costs & Expenses | $8.64M | $7.32M | $7.60M | $5.56M |
| Interest Income | $0.00 | $37443.00 | $26769.00 | $11174.00 |
| Interest Expense | $0.00 | $94999.00 | $70325.00 | $98998.00 |
| Depreciation & Amortization | $119340.00 | $117532.00 | $124028.00 | $120995.00 |
| EBITDA | $202200.00 | $53932.00 | -$1.65M | -$1.45M |
| EBITDA Ratio | $0.02 | $0.008 | -$0.27 | -$0.41 |
| Operating Income | $225857.00 | -$328493.00 | -$1.58M | -$1.70M |
| Operating Income Ratio | $0.03 | -$0.05 | -$0.26 | -$0.44 |
| Other Income/Expenses (Net) | -$129629.00 | $183674.00 | -$255570.00 | $37316.00 |
| Income Before Tax | $96228.00 | -$144819.00 | -$1.84M | -$1.67M |
| Income Before Tax Ratio | $0.01 | -$0.02 | -$0.31 | -$0.43 |
| Income Tax Expense | -$337167.00 | -$2.00 | -$314937.00 | -$327739.00 |
| Net Income | $433395.00 | -$144819.00 | -$1.53M | -$1.34M |
| Net Income Ratio | $0.05 | -$0.02 | -$0.25 | -$0.35 |
| EPS | $0.002 | -$0.001 | -$0.007 | -$0.007 |
| Diluted EPS | $0.002 | -$0.001 | -$0.007 | -$0.007 |
| Weighted Avg Shares Outstanding | $228.10M | $208.04M | $203.38M | $201.81M |
| Weighted Avg Shares Outstanding (Diluted) | $224.70M | $208.04M | $203.38M | $201.81M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan